Bristol-Myers Squibb Company (BMY): Price and Financial Metrics


Bristol-Myers Squibb Company (BMY)

Today's Latest Price: $66.74 USD

0.20 (0.30%)

Updated Jan 19 7:00pm

Add BMY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

BMY Stock Summary

  • BMY has a higher market value than 98.67% of US stocks; more precisely, its current market capitalization is $150,363,866,008.
  • BMY's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 7,142.73 -- higher than 99.57% of US-listed equities with positive expected earnings growth.
  • The volatility of Bristol Myers Squibb Co's share price is greater than that of just 0.41% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Bristol Myers Squibb Co are DDOG, TRUP, SYY, SBAC, and AMK.
  • Visit BMY's SEC page to see the company's official filings. To visit the company's web site, go to www.bms.com.

BMY Stock Price Chart Interactive Chart >

Price chart for BMY

BMY Price/Volume Stats

Current price $66.74 52-week high $68.34
Prev. close $66.54 52-week low $45.76
Day low $66.32 Volume 10,847,800
Day high $67.16 Avg. volume 12,391,618
50-day MA $62.67 Dividend yield 2.95%
200-day MA $60.75 Market Cap 151.01B

Bristol-Myers Squibb Company (BMY) Company Bio


Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular. The company was founded in 1887 and is based in New York, New York.


BMY Latest News Stream


Event/Time News Detail
Loading, please wait...

BMY Latest Social Stream


Loading social stream, please wait...

View Full BMY Social Stream

Latest BMY News From Around the Web

Below are the latest news stories about Bristol Myers Squibb Co that investors may wish to consider to help them evaluate BMY as an investment opportunity.

Sana Biotech Market Cap Expected to Top $10 Billion Post-IPO

Company's R&D aimed at cell replacement therapy for range of diseases

Yahoo | January 18, 2021

Bristol-Myers Squibb (BMY) Presents At 39th Annual JPMorgan Virtual Healthcare Conference - Slideshow

The following slide deck was published by Bristol-Myers Squibb Company in conjunction with this event....

SA Transcripts on Seeking Alpha | January 15, 2021

Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know

Bristol-Myers Squibb (BMY) closed the most recent trading day at $66.54, moving +0.79% from the previous trading session.

Yahoo | January 15, 2021

Is Bristol-Myers Squibb (BMY) Stock a Buy For 2021?

Wedgewood Partners recently released its Q4 2020 Investor Letter, a copy of which you can download here. The Fund returned 12.2% for the fourth quarter of 2020. Meanwhile, the benchmark S&P 500 Index and the Russell 1000 Growth Index gained 12.2% and 11.4%, respectively. You should check out Wedgewood Partners’ top 5 stock picks for […]

Yahoo | January 15, 2021

Bristol-Myers Squibb's Debt Overview

Over the past three months, shares of Bristol-Myers Squibb (NYSE: BMY) moved higher by 8.86%. Before having a look at the importance of debt, let us look at how much debt Bristol-Myers Squibb has.Bristol-Myers Squibb's Debt According to the Bristol-Myers Squibb's most recent financial statement as reported on November 5, 2020, total debt is at $44.95 billion, with $41.36 billion in long-term debt and $3.58 billion in current debt. Adjusting for $19.43 billion in cash-equivalents, the company has a net debt of $25.51 billion.Let's define some of the terms we used in the paragraph above. Current debt is the portion of a company's debt which is due within 1 year, while long-term debt is the portion due in more than 1 year. Cash equivalents include cash and any liquid securities with maturi...

Yahoo | January 15, 2021

Read More 'BMY' Stories Here

BMY Price Returns

1-mo 6.58%
3-mo 12.06%
6-mo 13.21%
1-year N/A
3-year 17.50%
5-year 22.05%
YTD 7.59%
2020 0.41%
2019 27.74%
2018 -12.90%
2017 7.71%
2016 -13.49%

BMY Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full BMY Dividend History

Continue Researching BMY

Here are a few links from around the web to help you further your research on Bristol Myers Squibb Co's stock as an investment opportunity:

Bristol Myers Squibb Co (BMY) Stock Price | Nasdaq
Bristol Myers Squibb Co (BMY) Stock Quote, History and News - Yahoo Finance
Bristol Myers Squibb Co (BMY) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6868 seconds.